Halozyme Therapeutics (HALO) has reportedly spent up to $1.3 billion in acquiring three biotech startups in recent months.

The patented Aerio™ platform was designed to meet the highest standards of device function and form from food allergies to ...

Targeted drug delivery has long been a cornerstone goal of modern medicine—sending therapies exactly where they’re needed while sparing healthy tissues. Yet creating treatments that can decide when ...

Researchers have developed RNA therapeutics, called micelles, that can delivery chemotherapeutic drugs to metastasized tumors in mouse models.

VANCOUVER, BC / ACCESS Newswire / February 17, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...

How do you send drugs to specific parts of the body so they do their job and avoid causing side effects elsewhere? According to researchers at Stanford University, the answer is a combination of ...

A couple of University of Nebraska professors have launched a startup company with the goal of bringing to market an innovative method for delivering drugs and other therapeutics to targeted locations ...

Polymer micelles are tiny, self-assembled particles that are revolutionizing the landscape of drug delivery and nanomedicine. They form when polymer chains containing both hydrophilic and hydrophobic ...

As medications advance, so do devices used for drug delivery. Pharmaceutical engineers and designers are focused on how to make drug delivery systems easier, less painful, more sustainable, and better ...